Physician profile
Sonya S Noor
NPI 1962481911
$990,902.85
in general payments reported to CMS, 2019-2025
45 companies · $130K in 2025
The $130K reported for 2025 was more than what 99% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $90K · 2020: $56K · 2021: $190K · 2022: $241K · 2023: $139K · 2024: $146K · 2025: $130K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $180K · Consulting Fee: $153K · Travel and Lodging: $49K · Food and Beverage: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,200 · Honoraria: $5,320 · Long Term Medical Supply Or Device Loan: $349 · Education: $11.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $180,324.10 |
| Consulting Fee | $152,575.00 |
| Travel and Lodging | $49,062.22 |
| Food and Beverage | $19,164.75 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,200.00 |
| Honoraria | $5,320.28 |
| Long Term Medical Supply Or Device Loan | $349.27 |
| Education | $11.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $403,783.78 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $272,555.89 | 2019-2025 | General - Therapies, Enroute Transcarotid Neuroprotection System, Eluvia |
| Endologix LLC | $165,707.54 | 2019-2025 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Silk Road Medical, INC. | $73,428.71 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inari Medical, INC. | $28,700.45 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $14,162.34 | 2020-2025 | Esprit, Diamondback Coronary, Diamondback Peripheral |
| Janssen Scientific Affairs, LLC | $9,418.25 | 2021-2024 | Xarelto |
| Cardiovascular Systems INC. | $7,714.27 | 2019-2023 | Diamondback Peripheral |
| Asahi Intecc USA, INC. | $5,438.38 | 2024-2025 | Asahi Peripheral Vascular Wires, Peripheral Vascular |
| Cordis US Corp. | $4,360.97 | 2022-2025 | Mynx Control Venous, Selution Slr Pta, Mynx Control |
| Philips North America LLC | $1,666.22 | 2019-2025 | Azurion 7 M12 |
| Tactile Systems Technology INC | $799.14 | 2023-2025 | Entre Plus, Flexitouch Plus, Flexitouch Plus |
| Terumo Medical Corporation | $617.52 | 2020-2025 | Navicross, Glidewire, Azur Cx Detachable |
| Integra Lifesciences Corporation | $420.95 | 2023-2025 | Amnioexcel Plus, Integra, Cytal |
| Angiodynamics, INC. | $321.39 | 2025 | Auryon Laser System 100-120 Vac |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $236.10 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Penumbra, INC. | $176.40 | 2020-2021 | |
| Mimedx Group, INC. | $168.21 | 2024-2025 | |
| Medtronic, INC. | $136.98 | 2021-2025 | Venaseal |
| Medtronic Vascular, INC. | $113.10 | 2019 | |
| Smith+Nephew, INC. | $98.65 | 2019-2020 | |
| Imperative Care, INC | $87.43 | 2024 | Symphony Catheter |
| W. L. Gore & Associates, INC. | $70.90 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Lemaitre Vascular, INC. | $67.33 | 2019-2023 | Artegraft Vascular Graft |
| Bard Peripheral Vascular, INC. | $62.00 | 2019-2021 | |
| Solventum Corporation | $55.77 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Organogenesis INC. | $51.57 | 2025 | Simplimax, Puraply Wound Matrix |
| Shape Memory Medical INC. | $50.75 | 2024-2025 | Impede Embolization Plug |
| Polynovo North America LLC | $48.86 | 2024-2025 | Novosorb Btm |
| Ekos Corporation | $45.78 | 2019 | |
| Cook Medical LLC | $38.00 | 2022-2025 | Rosen |
| Kci USA, INC. | $36.43 | 2019 | |
| Bsn Medical INC | $30.70 | 2025 | |
| Cvrx, INC. | $29.02 | 2022 | |
| Acera Surgical, INC. | $28.26 | 2023 | Restrata Wound Matrix |
| Reflow Medical INC | $27.13 | 2025 | |
| Biotronik INC. | $26.52 | 2025 | Orsiro Mission |
| Urgo Medical North America, LLC | $26.14 | 2025 | Urgok2 |
| Inspiremd Ltd | $22.00 | 2023-2024 | Cguard |
| Djo, LLC | $21.68 | 2025 | Aircast |
| Convatec INC. | $13.82 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $13.36 | 2019 | |
| Pfizer INC. | $12.93 | 2022 | |
| Surmodics, INC. | $11.23 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$900.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Noor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.